CD274 and neoplasm: Consistently, the corresponding immune checkpoint ligands CD274 (PD‐L1) and PDCD1LG2 (PD‐L2) were barely expressed in both cancer cells and other infiltrating immune/stromal cells in the tumor microenvironment.